Cargando…
Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing
There was a global shortage of nab-paclitaxel (Abraxane(Ⓡ)), a major antineoplastic agent, for a long period (from October 2021 to June 2022) because of manufacturing problems. Japan was one of the first affected countries by the depletion, and the medical institutes started to save the use of the d...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169259/ https://www.ncbi.nlm.nih.gov/pubmed/37179729 http://dx.doi.org/10.31662/jmaj.2022-0179 |
_version_ | 1785039017995141120 |
---|---|
author | Oura, Mitsuaki Saito, Hiroaki Nishikawa, Yoshitaka |
author_facet | Oura, Mitsuaki Saito, Hiroaki Nishikawa, Yoshitaka |
author_sort | Oura, Mitsuaki |
collection | PubMed |
description | There was a global shortage of nab-paclitaxel (Abraxane(Ⓡ)), a major antineoplastic agent, for a long period (from October 2021 to June 2022) because of manufacturing problems. Japan was one of the first affected countries by the depletion, and the medical institutes started to save the use of the drug in August 2021; numerous patients with gastric, breast, and lung cancer who potentially could receive benefits failed to be treated with the antineoplastic agent; thus, they opted for alternative treatments. Meanwhile, the hospitals in the United States and some countries continued to consume nab-paclitaxel at a regular pace as usual and then the worldwide depletion occurred in October 2021. Early communications about the drug shortage between authorities worldwide might have soothed the depletion; effective platforms for global information sharing would be necessary in order to secure the access to anticancer agents. |
format | Online Article Text |
id | pubmed-10169259 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Japan Medical Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-101692592023-05-10 Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing Oura, Mitsuaki Saito, Hiroaki Nishikawa, Yoshitaka JMA J Opinion There was a global shortage of nab-paclitaxel (Abraxane(Ⓡ)), a major antineoplastic agent, for a long period (from October 2021 to June 2022) because of manufacturing problems. Japan was one of the first affected countries by the depletion, and the medical institutes started to save the use of the drug in August 2021; numerous patients with gastric, breast, and lung cancer who potentially could receive benefits failed to be treated with the antineoplastic agent; thus, they opted for alternative treatments. Meanwhile, the hospitals in the United States and some countries continued to consume nab-paclitaxel at a regular pace as usual and then the worldwide depletion occurred in October 2021. Early communications about the drug shortage between authorities worldwide might have soothed the depletion; effective platforms for global information sharing would be necessary in order to secure the access to anticancer agents. Japan Medical Association 2023-03-24 2023-04-14 /pmc/articles/PMC10169259/ /pubmed/37179729 http://dx.doi.org/10.31662/jmaj.2022-0179 Text en Copyright © Japan Medical Association https://creativecommons.org/licenses/by/4.0/JMA Journal is an Open Access journal distributed under the Creative Commons Attribution 4.0 International License. To view the details of this license, please visit (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ). |
spellingShingle | Opinion Oura, Mitsuaki Saito, Hiroaki Nishikawa, Yoshitaka Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title | Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title_full | Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title_fullStr | Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title_full_unstemmed | Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title_short | Shortage of Nab-paclitaxel in Japan and around the World: Issues in Global Information Sharing |
title_sort | shortage of nab-paclitaxel in japan and around the world: issues in global information sharing |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169259/ https://www.ncbi.nlm.nih.gov/pubmed/37179729 http://dx.doi.org/10.31662/jmaj.2022-0179 |
work_keys_str_mv | AT ouramitsuaki shortageofnabpaclitaxelinjapanandaroundtheworldissuesinglobalinformationsharing AT saitohiroaki shortageofnabpaclitaxelinjapanandaroundtheworldissuesinglobalinformationsharing AT nishikawayoshitaka shortageofnabpaclitaxelinjapanandaroundtheworldissuesinglobalinformationsharing |